BioSpace News Archive

Press Releases

Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results

March 30, 2026
·
17 min read
Press Releases

INmune Bio Inc. Announces 2025 Results and Provides Business Update

March 30, 2026
·
15 min read
Press Releases

Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results

March 30, 2026
·
14 min read
Press Releases

Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results

March 30, 2026
·
9 min read
Press Releases

Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease

March 30, 2026
·
8 min read
Press Releases

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

March 30, 2026
·
10 min read
Press Releases

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

March 30, 2026
·
5 min read
Press Releases

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

March 30, 2026
·
4 min read
Press Releases

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

March 30, 2026
·
3 min read
Press Releases

Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

March 30, 2026
·
10 min read